Related Experiment Videos
Summary
High doses of purified lipopolysaccharide (LPS) from E. coli caused illness but no chick deaths. Uric acid did not prevent LPS-induced reactions, and Shwartzman-like reactions were not observed.
Area of Science:
- Veterinary immunology
- Pathogen-associated molecular patterns
- Avian disease models
Background:
- Lipopolysaccharide (LPS) from Gram-negative bacteria like Escherichia coli is a potent immune stimulant.
- Understanding LPS toxicity and immune responses in avian species is crucial for poultry health.
- The Shwartzman reaction is a severe inflammatory response often associated with bacterial endotoxins.
Purpose of the Study:
- To investigate the effects of high-dose lipopolysaccharide (LPS) administration in chicks.
- To determine if uric acid can confer protection against LPS-induced toxicity.
- To assess the potential for inducing a generalized Shwartzman-like reaction in chicks using LPS.
Main Methods:
- Purified lipopolysaccharide (LPS) from Escherichia coli was administered in large doses to chicks.
- Survival rates and clinical signs were monitored following LPS exposure.
- Attempts were made to induce a Shwartzman-like reaction through sequential LPS injections.
- The protective effect of prior uric acid injection against LPS was evaluated.
Main Results:
- Large doses of LPS induced clinical signs in chicks, but no mortality was observed.
- Chicks survived mean doses up to 517 mg/kg, with one recovering from 577 mg/kg.
- Sequential LPS injections failed to elicit a generalized Shwartzman-like reaction.
- Pre-treatment with uric acid did not protect chicks from the effects of intravenous LPS.
Conclusions:
- Chicks exhibit significant tolerance to high doses of purified LPS from E. coli.
- The Shwartzman reaction is not readily inducible in chicks via this LPS model.
- Uric acid does not provide protection against acute LPS toxicity in this avian model.